BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12210913)

  • 21. Measurements of alveolar pO2 using 19F-MRI in partial liquid ventilation.
    Heussel CP; Scholz A; Schmittner M; Laukemper-Ostendorf S; Schreiber WG; Ley S; Quintel M; Weiler N; Thelen M; Kauczor HU
    Invest Radiol; 2003 Oct; 38(10):635-41. PubMed ID: 14501491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of alveolar type II cells and intraalveolar surfactant after bronchoalveolar lavage and perfluorocarbon ventilation. An electron microscopical and stereological study in the rat lung.
    Rüdiger M; Wendt S; Köthe L; Burkhardt W; Wauer RR; Ochs M
    Respir Res; 2007 Jun; 8(1):40. PubMed ID: 17550584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of conventional surfactant treatment and partial liquid ventilation on the lung volume of injured ventilated small lungs.
    Proquitté H; Hartenstein S; Koelsch U; Wauer RR; Rüdiger M; Schmalisch G
    Physiol Meas; 2013 Aug; 34(8):915-24. PubMed ID: 23893018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Proton MRI in Emphysematous Rats.
    Bianchi A; Tibiletti M; Kjørstad Å; Birk G; Schad LR; Stierstorfer B; Stiller D; Rasche V
    Invest Radiol; 2015 Dec; 50(12):812-20. PubMed ID: 26146872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of work of breathing in spontaneously breathing animals during partial liquid ventilation.
    Heulitt MJ; Holt SJ; Wilson S; Simpson P
    Respir Care; 2002 Jan; 47(1):39-47. PubMed ID: 11749686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of changes in respiratory mechanics during partial liquid ventilation using jet pulses.
    Schmalisch G; Schmidt M; Proquitté H; Foitzik B; Rüdiger M; Wauer RR
    Crit Care Med; 2003 May; 31(5):1435-41. PubMed ID: 12771615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative mapping of ventilation-perfusion ratios in lungs by 19F MR imaging of T1 of inert fluorinated gases.
    Adolphi NL; Kuethe DO
    Magn Reson Med; 2008 Apr; 59(4):739-46. PubMed ID: 18383306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary functional MRI: an animal model study of oxygen-enhanced ventilation combined with Gd-DTPA-enhanced perfusion.
    Yang J; Wan MX; Guo YM
    Chin Med J (Engl); 2004 Oct; 117(10):1489-96. PubMed ID: 15498371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, randomized pilot trial of perfluorocarbon-induced lung growth in newborns with congenital diaphragmatic hernia.
    Hirschl RB; Philip WF; Glick L; Greenspan J; Smith K; Thompson A; Wilson J; Adzick NS
    J Pediatr Surg; 2003 Mar; 38(3):283-9; discussion 283-9. PubMed ID: 12632336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of positive end-expiratory pressure during partial liquid ventilation in newborn lambs.
    Overfield DM; Bennett SH; Goetzman BW; Milstein JM; Moon-Grady AJ
    J Pediatr Surg; 2001 Sep; 36(9):1327-32. PubMed ID: 11528599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfluorocarbon dosing when starting partial liquid ventilation: haemodynamics and cerebral blood flow in preterm lambs.
    Davies MW; Dunster KR; Wilson K; Colditz PB
    Neonatology; 2010; 97(2):144-53. PubMed ID: 19776648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model.
    von der Hardt K; Schoof E; Kandler MA; Dötsch J; Rascher W
    Pediatr Res; 2002 Feb; 51(2):177-82. PubMed ID: 11809911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR imaging of the lung using liquid perfluorocarbons.
    Thomas SR; Clark LC; Ackerman JL; Pratt RG; Hoffmann RE; Busse LJ; Kinsey RA; Samaratunga RC
    J Comput Assist Tomogr; 1986; 10(1):1-9. PubMed ID: 2935563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An advanced expiratory circuit for the recovery of perfluorocarbon liquid from non-saturated perfluorocarbon vapour during partial liquid ventilation: an experimental model.
    Dunster KR; Davies MW; Fraser JF
    Biomed Eng Online; 2006 Feb; 5():7. PubMed ID: 16457722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional MRI using Fourier decomposition of lung signal: reproducibility of ventilation- and perfusion-weighted imaging in healthy volunteers.
    Lederlin M; Bauman G; Eichinger M; Dinkel J; Brault M; Biederer J; Puderbach M
    Eur J Radiol; 2013 Jun; 82(6):1015-22. PubMed ID: 23295084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
    Neubauer AM; Caruthers SD; Hockett FD; Cyrus T; Robertson JD; Allen JS; Williams TD; Fuhrhop RW; Lanza GM; Wickline SA
    J Cardiovasc Magn Reson; 2007; 9(3):565-73. PubMed ID: 17365236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary stretch receptor activity during Partial Liquid Ventilation in Cats with Healthy Lungs.
    Rieger-Fackeldey E; Sindelar R; Jonzon A; Schulze A; Sedin G
    Biol Neonate; 2004; 86(2):73-80. PubMed ID: 15084808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liquid ventilation with perfluorocarbons].
    Quintel M; Waschke KF; Meinhardt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):461-9. PubMed ID: 9019174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution dynamics of perfluorocarbon delivery to the lungs: an intact rabbit model.
    Bull JL; Tredici S; Komori E; Brant DO; Grotberg JB; Hirschl RB
    J Appl Physiol (1985); 2004 May; 96(5):1633-42. PubMed ID: 14688037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfluoropropane gas as a magnetic resonance lung imaging contrast agent in humans.
    Halaweish AF; Moon RE; Foster WM; Soher BJ; McAdams HP; MacFall JR; Ainslie MD; MacIntyre NR; Charles HC
    Chest; 2013 Oct; 144(4):1300-1310. PubMed ID: 23722696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.